IMPORTANT MESSAGE REGARDING COVID-19

News

United States Settles With South Carolina Hospital for $72.4 Million After $237 Million Judgment

On October 4, 2005, whistleblower Dr. Michael K. Drakeford, an orthopedic surgeon, filed a False Claims Act lawsuit against Tuomey Healthcare System for violations of the Stark Laws on behalf of the United States. The government intervened and took over the action.

The case alleged that Tuomey violated the Stark Law, which prohibits health care providers from billing Medicare for...

Merch Mariner’s Son-Meso Award $9.936M

$9.936M Awarded to Son of Merchant Mariner for Household Exposure to Asbestos

45-Year-Old Man Diagnosed with Mesothelioma in 2007, 35 Years After Exposure to Asbestos Dust on Father’s Work Clothes

BALTIMORE, Md. – January 27, 2010 – A Baltimore City jury yesterday awarded $9.936 million to the son of a merchant mariner who suffers with...

Toxic Exposure Causes Birth Defects, Not Birth Injuries

One of the primary causes ofbirth defects in the United States is the parent’s exposure to toxic chemicals. According to the Centers for Disease Control, one baby in 33 will suffer from a birth defect. Some of the toxic substances that can cause birth defects include coal ash, pesticides used in the agricultural industry, and toxic chemicals used to manufacture conductor...

Stronger Pesticide Regulation Protects Workers and Children

Pesticides have been shown in repeated studies to cause birth defects, cancer and neurological problems. Yet American farmworkers are routinely exposed to dangerous pesticides. As part of their jobs, they are often exposed when they mix up batches of pesticides to spray on crops and then again as they apply the pesticides in the fields.

EPA Strengthens Pesticide Regulations

New safety...

Mesothelioma Drug Fails in Phase II Testing

A mesothelioma drug that once held promise for patients and their families has failed to live up to everyone’s hope. In a phase II clinical trial, defactinib (VS-6063) proved to be no more effective than a placebo.

Defactinib (VS-6063) Clinical Trial Ceases Enrollment

Defactnib is manufactured by Verastem, a Boston biopharmaceutical company. Defactnib is designed to attack malignant...

Florida Hospital Pays $69.5 Million to Settle False Claims Act Case

October 12, 2015 — North Broward Hospital District (“Broward Health”), a taxpayer financed system of hospitals and health facilities, agreed to pay $69.5 million to settle federal charges that it made illegal payments to physicians using a secret compensation system that rewarded doctors for patient referrals and penalized them for accepting low income patients. The False Claims...

Monitoring Benzene Levels Prevents Harmful Exposure

Dangerous benzene exposure is a risk for workers and for those in the community living near petroleum refineries where ambient benzene occurs around the fence to the plant. Benzene exposure causes a number of blood cancers and diseases, such as acute myeloid leukemia (AML) and myelodysplastic syndrome.

Wireless Gas Monitoring Systems Available to Cut Risk of Benzene Exposure

For...

New Mesothelioma Treatment Center in Baltimore

A new mesothelioma treatment center has been launched at the University of Maryland School of Medicine in Baltimore. For decades, thousands of American workers were exposed to asbestos in Baltimore-area steel mills and shipyards. Asbestos exposure is the only established cause of pleural mesothelioma, a painful and aggressive cancer. Each year, 3,000 Americans are diagnosed with...

Drug Manufacturer Coupons as Kickbacks to Medicare Beneficiaries

On September 1, 2015, the Department of Justice announced that Kmart resolved a whistleblower’s allegations that it violated the False Claims Act by offering improper inducements to Medicare beneficiaries. The whistleblower in the case, Joshua Leighr, was a pharmacist who worked in various Springfield, MO-area Kmart pharmacies. While there, he witnessed various Kmart schemes intended to...

Vaginal Mesh Complication Risk: 1 in 30

A decade-long study of almost 60,000 Canadian womenreportedly has revealed that an alarming 1 in 30 women treated with transvaginal mesh (TVM) will suffer pain, bleeding or other complications so severe that a second surgery is required. The troubling findings on this medical device have been published in JAMA Surgery.

Canadian Study Reveals that 1 in 30 Vaginal Mesh Patients Need Second...

What are my chances?

That’s the first question everyone asks. The truth is it’s impossible to know. But we can tell you this. Waters Kraus & Paul has what it takes to fight against big corporate interests and win. That’s why we’ve taken more mesothelioma trials to verdict than any other firm. And that’s why we’ve recovered more than $1.3 billion for clients like you. Do you think you have a case? Contact us now to speak with an attorney.

Call 800.226.9880